SCHEMBL4553947

SCHEMBL4553947

COc1cc(CCc2cc(N(CC(C)=C(Cl)N(C)C)C(=O)c3cccc(OC)c3)n[nH]2)cc(OC)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR2 P21802 11/20 0.39
FGFR1 P11362 7/20 0.38
FGFR3 P22607 7/20 0.38
NTRK1 P04629 1/20 0.37
RET P07949 1/20 0.37
PDGFRB P09619 1/20 0.37
MARK3 P27448 1/20 0.37
TNK2 Q07912 1/20 0.37
DDR1 Q08345 1/20 0.37
MAP4K2 Q12851 1/20 0.37
MAP3K11 Q16584 1/20 0.37
DDR2 Q16832 1/20 0.37
MARK2 Q7KZI7 1/20 0.37
MAP4K3 Q8IVH8 1/20 0.37
MAP4K1 Q92918 1/20 0.37
AURKB Q96GD4 1/20 0.37
EIF2AK1 Q9BQI3 1/20 0.37
MAP3K20 Q9NYL2 1/20 0.37
STK26 Q9P289 1/20 0.37
TNIK Q9UKE5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4553948 0.77 FGFR1 (0.55) FGFR2FGFR1FGFR3NTRK1RET
SCHEMBL63114 0.70 FGFR2 (0.62) FGFR2FGFR1FGFR3NTRK1RET
SCHEMBL21430743 0.63 FGFR1 (0.67) FGFR2FGFR1FGFR3NTRK1RET
SCHEMBL2540656 0.63 CES2 (0.67) F10HSD17B10
SCHEMBL30870831 0.63 CES2 (0.67) F10HSD17B10
SCHEMBL23409092 0.62 FGFR2 (0.60) FGFR2FGFR1FGFR3NTRK1RET
SCHEMBL16070500 0.62 HCAR2 (0.62) FGFR2FGFR1FGFR3FGFR4
SCHEMBL4553990 0.62 FGFR1 (0.46) FGFR2FGFR1FGFR3NTRK1RET
SCHEMBL21425705 0.61 MEN1 (0.60) POLBHPGDRECQLCDK4CCND1
SCHEMBL9416583 0.61 HSD17B2 (0.74) POLBHPGDRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2125748-A2 ACYLAMINOPYRAZOLES AS FGFR INHIBITORS AstraZeneca AB (SE) 2009-12-02 EP disclosed
WO-2008075068-A2 ACYLAMINOPYRAZOLES AS FGFR INHIBITORS ASTRAZENECA AB (SE) 2008-06-26 WO disclosed